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1. Introduction
Current clinical therapies do not predict-
ably reconstruct the bone–ligament inter-
faces of tooth-supporting tissues damaged 
by trauma or periodontal disease. The 
regeneration of periodontal tissue sup-
porting structures requires the considera-
tion of specific anatomical architectures. 
The alveolar bone–periodontal ligament 
(PDL)–cementum complex consists of 
alveolar bone and bundle bone that houses 
ligamentous Sharpey’s fibers; these fibers 
anchor the PDL to the cementum, a min-
eralized layer that covers the tooth root.[1] 
The development of biomaterial systems 
for regenerating these complex tissues 
must necessarily consider the scaffold 
material, shape, and topography, as well as 
the inclusion of growth factors and cells.
Several studies have examined scaffold 
designs and growth factors that support 
multitissue regeneration relevant to peri-
odontal tissue engineering.[2] Material sur-
face topography, such as roughness, is an 
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important parameter in determining cellular response.[3] It has 
been shown that fibroblasts have a preference for attaching to 
smooth surfaces,[4] while bone-derived cells prefer surfaces that 
are rough.[5] In terms of organized microtopography, grooves of 
10 µm width have been shown to increase the adhesion and via-
bility of osteoblastic cells.[5,6] As such, micropatterned scaffolds 
have been developed that incorporate grooves in the PDL region 
to mimic the oblique orientation of native PDL. This design was 
shown to promote the alignment of individual cells and subse-
quent collagenous tissue formation in vivo.[7] Regarding growth 
factors, bone morphogenetic protein-7 (BMP-7) is a growth and 
differentiation factor important for stimulating the migration, 
angiogenesis, and differentiation of mesenchymal stem cells 
into bone-forming cells and cartilage.[8] Platelet-derived growth 
factor (PDGF) has been shown to promote the regeneration of 
alveolar bone, PDL, and cementum. The isoform PDGF-BB, in 
particular, has been shown to safely and effectively treat peri-
odontal osseous defects.[8,9]
Gene therapy-based growth factor delivery in combination 
with scaffolds has been suggested as a promising therapeutic 
approach for periodontal regeneration.[10] These vectors can 
be delivered via adenoviruses. In a recent study, the use of a 
mesoporous bioglass (MBG)/silk fibrin scaffold delivering ade-
noviruses encoding the gene for BMP-7 (AdBMP-7) and others 
encoding PDGF-B (AdPDGF-B) promoted periodontal regen-
eration in periodontal defects.[11] Similar results were reported 
for chitosan/collagen scaffolds that delivered AdBMP-7 or 
AdPDGF-B..[12]
Despite the successful use of gene therapy in combination 
with scaffolds for periodontal regeneration, a major limitation 
of using gene therapy vectors has been the lack of spatiotem-
poral control of gene expression. This concerns potential vector 
dispersion. To address this limitation, Lahann et al. developed 
chemical vapor deposition (CVD)-based polymer coatings that 
use antibodies to tightly immobilize gene therapy vectors onto 
FDA-approved biomaterials, including polycaprolactone (PCL) 
and polylactic-co-glycolic acid (PLGA).[13,14] The CVD technique 
may represent an innovative method for targeting the effects of 
gene therapy to specific tissues or regions.[15–17] In fact, surface 
modification using polymer coatings represents an effective 
means of delivering gene therapy vectors. Adenoviral vectors 
have been shown to efficiently deliver growth factor genes that 
are expressed over finite periods of time.[18] To mitigate random 
release and systemic dispersion, the CVD method covalently 
immobilizes the adenoviruses onto the material’s surface via 
antigen–antibody interactions. Moreover, by adjusting the 
amount of vector attached to the surface and its site of locali-
zation, CVD provides a way to establish a biological signaling 
gradient.[16]
In a model relevant to periodontal regeneration, Hao et al. 
showed that CVD-immobilized AdPDGF-BB and AdBMP-7 
could efficiently transduce seeded human PDL cells and pro-
duce considerable levels of PDGF-BB and BMP-7 protein in 
vitro.[14] In addition, the combination of gene delivery with 
3D-printed scaffolding, wherein one scaffold region had immo-
bilized AdBMP-7 and the other had AdPDGF-BB, demonstrated 
compartmentalized gene expression.
Therefore, the present study aimed to evaluate the com-
bined effects of growth factor gene delivery on micropatterned 
scaffolds to regenerate periodontal defects in vivo. 
Micropatterned, PLGA/PCL scaffolds were designed to regen-
erate ligamentous structures and amorphous PCL scaffolds 
were designed to regenerate bone. Using the CVD technique, 
the former were immobilized with AdPDGF-BB, and the latter 
with AdBMP-7. The scaffolds were then seeded with human 
fibroblasts and implanted into large osseous fenestration 
defects, and their ability to regenerate bone and ligamentous 
tissue was evaluated at 3, 6, and 9 weeks.
2. Results and Discussion
2.1. Design of Patterned Scaffolds and Spatially Controlled 
Immobilization of Gene Therapy Vectors
The present study aimed to evaluate how the combination of 
scaffold topography and growth factor gene delivery could 
enhance periodontal tissue repair. The experimental treat-
ment consisted of a biphasic scaffold, having a micropat-
terned, PLGA/PCL region that delivered AdPDGF-BB to 
promote PDL tissue regeneration, and an amorphous, PCL 
region that delivered AdBMP-7 to promote bone regeneration 
(Figure 1A). Here, the micropatterned pillars had grooves of 
15 µm width and 30 µm depth, which were based on previ-
ously established parameters shown to promote the formation 
of aligned collagenous tissue.[7] Grooved pillars were oriented 
toward the tooth root and designed to align newly formed liga-
mentous tissue in the oblique orientation of native PDL. The 
bone region was placed directly on top. The scaffold regions 
were each 250 µm thick, for a combined thickness of 500 µm, 
providing a calculated fit within a 500 µm deep, osseous fen-
estration defect (Figure 1). Adenoviruses were immobilized 
onto the scaffold surfaces using CVD to locally deliver gene 
vectors. Other groups included the single delivery of AdBMP-7 
on both regions of the scaffold, which was selected based on 
a previous publication indicating that treatment of periodontal 
defects with ex vivo gene transfer of BMPs only resulted in 
cementogenesis, bridging of periodontal bone defects, as well 
as evidence of initial PDL-like tissue formation.[10] The negative 
controls delivered no genes (Ad-empty vectors) with or without 
a micropatterned PDL region. This pattern may have resulted 
in an osteoconductive effect, which would explain the ingrowth 
of bone even for the patterned group devoid of the gene 
delivery. The pattern may have even been more osteoconduc-
tive than the amorphous bone region, which was designed to 
be osteoconductive.
In the present study, scanning electron microscopy (SEM) 
images of CVD-coated scaffolds confirmed the micropat-
terned architecture and porosity of the scaffold (Figure 1B), as 
well as the immobilization of adenovirus particles on its sur-
faces (Figure 1C). Previously, it was shown that viral particles 
can be immobilized with even distribution on various sur-
faces, including nonporous PLGA and PCL.[19] In this study, 
the virus was confirmed to be immobilized onto the porous 
PCL (Figure 1C) and patterned PCL/PLGA (Supplementary 
Figure 3) compartments. To further investigate cell behavior 
and alignment on the patterned films, human periodontal liga-
ment (hPDL) cells were seeded on the films for 72 h, fixed, and 
Adv. Healthcare Mater. 2018, 7, 1800750
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1800750 (3 of 11)
www.advancedsciencenews.com www.advhealthmat.de
analyzed using SEM. Images showed cell alignment along the 
pillar grooves as well as at the interpillar spaces (Figure 1D). 
Together, these findings indicate that the cells seeded onto the 
CVD-treated surface intended to promote their transduction 
with the adenoviral vector are induced to align due to the pres-
ence of incorporated micropatterns within the polymer surface, 
with the intention of sustaining this alignment as the cells con-
tinue to proliferate. Therefore, part of this study’s goal was to 
incorporate these patterned, cell-seeded constructs into a fenes-
tration defect to observe their ability to support cell alignment 
and subsequent tissue regeneration over the long term.
2.2. Osseous Defect Creation and New Bone Formation
Fenestration defects of 2 mm × 3 mm were surgically created 
in the animals’ mandibulae, removing not only the alveolar 
bone but also the cementum and other soft tissue structures 
(Supporting Information, Figure 1A). The scaffolds were placed 
inside and evaluated for their ability to regenerate the bone–
ligament interface after 3, 6, and 9 weeks in vivo.
Microcomputed tomography (Micro-CT) scans were per-
formed at three and six weeks postimplantation to evaluate 
new bone formation. At three weeks, considerably greater bone 
regeneration was observed for groups with growth factor gene 
delivery, compared to those with Ad-empty vector (Figure 2A), 
where the root largely remained exposed. These differ-
ences manifested in significantly greater bone volume for all 
groups with gene delivery relative to Ad-empty at three weeks 
(Figure 2B). There were no differences between the groups with 
gene delivery, suggesting that the single delivery of BMP-7 pro-
vided no advantage in bone formation over the dual delivery of 
BMP-7 and PDGF-BB. The percentage of the defect filled with 
new bone was also greater for two of the three gene delivery 
groups relative to Ad-empty, particularly for Pattern+Single and 
Amor+Dual (Figure 2C).
By six weeks, all groups except for the negative control dem-
onstrated nearly complete bone coverage of the tooth roots. 
Differences in the bone volume between groups largely abated, 
except for greater volume for Amor+Dual relative to the nega-
tive control (Figure 2B). By six weeks, enough time had passed 
for self-repair capacity. However, two of the three gene delivery 
groups, including the experimental group, did maintain sig-
nificantly greater bone fill percent than the negative control 
(Figure 2C).
Tissue mineral density (TMD), a measure of mineralized 
tissue maturity and measured by micro-CT, showed little varia-
tion between groups at three or six weeks, save for greater TMD 
for the negative control relative to the single gene delivery at 
three weeks (Figure 2D).
Of note, cementum regeneration was minimally observed 
in the present study. Specifically, regions which are expected 
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Figure 1. Scaffold design for periodontal tissue neogenesis. A) Schematic representation of the polymeric scaffolds, designed to deliver gene therapy 
vectors and/or micropatterned surface topography to the bony defects. The PDL regions were either patterned or amorphous, made of PLGA/PCL, and 
seeded with human periodontal ligament cells (hPDLs), except Pattern+Single, which received hGFs. The bone regions were amorphous, made of PCL, 
and seeded with human gingival fibroblasts (hGFs). All regions were CVD-coated to immobilize adenoviral genes for Ad-BMP-7 (blue), Ad-PDGF-BB 
(yellow), or Ad-empty (gray). B) SEM images of patterned PDL region, showing the pillar and groove dimensions. C) SEM images of CVD-coated, PCL, 
porous base with immobilized adenoviral particles (1012 PN mL−1). D) SEM images of hPDLs aligned with the micropatterning, 3 d after seeding. Blue 
arrows indicate the alignment of cells along the grooves embedded within the scaffold pillars, as well as in the interpillar regions.
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to display cementum formation at times appear as gaps 
between the tooth root surface and PDL-like tissue forma-
tion (Figure 3A) due to artifactual separation during his-
tological processing, given that there is a lack of Sharpey’s 
fiber formations that can stabilize the PDL-like tissue in 
place. Overall, while this study shows a lack of cementum 
formation which is necessary in periodontal tissues, further 
improvements in scaffold design are likely to improve this 
outcome, although formation of the cementum–PDL tissue 
complex is a challenge in numerous models. Intriguingly, 
Sowmya et al. recently were able to promote the formation 
of cementum using a trilayered nanocomposite hydrogel 
scaffold to deliver cells and growth factors to rabbit maxil-
lary periodontal defects.[20] Each layer targeted the regenera-
tion of cementum (made of chitin-PLGA/nano-bioactive glass 
ceramic [nBGC] and delivered cementum protein 1), PDL 
(chitin-PLGA with FGF-2), or alveolar bone (chitin/PLGA/
nBGC with platelet-rich plasma growth factors). Implanta-
tion of the scaffold with growth factors resulted in com-
plete closure of the defect, tissue healing, and confirmed 
regeneration of cementum, fibrous PDL, and alveolar bone 
at one and three months—better than scaffold alone. These 
results may indicate that a separate growth factor or scaf-
fold compartment may be more beneficial in order to more 
predictably repair cementum and ensure the formation of 
the full, trilayer periodontal complex.
2.3. PDL-Like Tissue Formation, Assessed by Histology and 
Immunofluorescence
The formation of ligamentous soft tissue was evaluated at 
three and six weeks postimplantation using histology. Hema-
toxylin and eosin (H&E) staining showed the formation of 
soft tissue for all groups by three weeks (Figure 3A). How-
ever, the tissue of groups with patterned scaffolds was more 
likely to be aligned obliquely with the tooth root, like native 
PDL. By six weeks, this was even more so: the newly formed 
soft tissue of patterned groups, as well as Amor+Dual, had 
generated more of an oblique angle, while the negative con-
trol had not.
Toluidine blue staining was used to measure the mean width 
of the new soft tissue (Figure 3B). Interestingly, only the soft 
tissue of patterned groups closely approximated the width 
of native rat PDL, which was ≈100 µm (Figure 3C). At three 
weeks, the widths for the three patterned groups were statisti-
cally indistinguishable from 100 µm, while those for the amor-
phous groups well exceeded 200 µm and were significantly 
Adv. Healthcare Mater. 2018, 7, 1800750
Figure 2. Micropatterned scaffolds and gene therapy promote new bone formation. A) Micro-CT isosurface images show the regenerated bone in the 
fenestration defects after three and six weeks for representative samples of each group. Arrows point to areas of considerable root coverage by new bone. 
B) New bone volume after three and six weeks. C) Percentage fill of the defect (n = 6–10). D) Tissue mineral density of the new bone (n = 6–10 animals 
per group). Data shown as mean ± SD. Statistics performed as one-way ANOVA with Tukey’s post hoc comparisons within each time point and 
two-sided p-values of *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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greater than those of all three patterned groups. At six weeks, 
the same result held, although the 95% confidence intervals 
for Pattern+Empty and Pattern+Single exceeded 100 µm. The 
micropatterning resulted in the generation of soft tissue pos-
sessing widths more consistent with native PDL. As mentioned 
earlier, the effects of surface topography may also explain the 
formation of new bone in front of the patterned scaffolds 
(Figure 3B). In effect, this result is contradictive to the scaf-
fold design, within which the pattern is intended to promote 
aligned tissue formation. However, it is interesting to note that 
nonetheless there is presence of PDL-like tissue alignment in 
front of the bone region infiltrating into the interpillar regions, 
indicating that the osteoconductive nature of the patterning is 
not necessarily a counterproductive result to the regenerative 
process, and may in fact contribute to the resulting tissue align-
ment. This is likely due to the expression of BMP-7 by gingival 
fibroblasts transduced by AdBMP-7 on the PCL porous base 
region of the scaffold, resulting in increased expression of 
the growth factor and its presence in scaffold regions of the 
defect not intended for the stimulation of bone formation. 
At the same time, the presence of the patterning introduces 
another preferable condition for bone formation, specifically 
the presence of pillars that act as anchors for osseous tissue 
formation in an osteoconductive manner. While this was a 
surprising finding here, further investigation of the literature 
confirms that such an effect does exist, with studies showing 
that presence of microstructures in titanium (Ti)-based 
bone substitutes resulted in excellent osteoconduction.[21]  
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Figure 3. Micropatterned scaffolds with gene delivery promote ligamentous-like tissues in vivo. A) Hematoxylin and eosin staining shows the soft 
tissue formation at the defect site. Arrows indicate the general orientation of cell nuclei relative to the tooth root. Brackets indicate the soft tissue 
region, and boxes indicate the magnified regions in the images below. TR = tooth root, AS = amorphous scaffold, PS = patterned scaffold, and B = 
bone. B) Toluidine blue staining was used to measure soft tissue width. A representative slide of Pattern+Dual is shown. Blue arrows represent the 
three measurements averaged to determine the soft tissue width, the region of the total initial defect is outlined in green, and the region of new bone 
formation (B) is outlined in yellow. C) Measurements of soft tissue width from toluidine blue staining (n = 3–6 per group). Data shown as mean ± SD. 
Statistics performed as one-way ANOVA with Tukey’s post hoc comparisons within each time point and two-sided p-values of *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001.
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Likewise, incorporation of microstructures onto Ti implant sur-
faces, such as nano/micro nest-like and nanotubes structures, 
has been shown to improve osteointegration, which requires 
the formation of bone.[22] Future improvements to the scaf-
fold design would account for this osteoconductive behavior 
by ensuring improved control of growth factor expression in 
scaffold regions (i.e., potentially reduced number of transduced 
human gingival fibroblasts (hGF) cells to lower BMP-7 expres-
sion outside of designated bone region), while also redesigning 
the scaffold construct such that there is direct contact of the 
scaffold region supporting PDL-like tissue formation with the 
tooth root.
Immunofluorescence staining provided evidence that the 
new soft tissue was more mature and PDL-like for the groups 
with combined patterning and gene delivery. PDL-specific 
periostin has been shown to positively regulate PDL cell min-
eralization and differentiation and be involved in maintaining 
the homeostasis of periodontal tissues.[23] Periostin is a matri-
cellular molecule and mesenchymal stem cell marker that is 
found in collagen-rich connective tissues, such as tendons 
and periosteum. At six weeks, the groups with gene delivery 
showed greater qualitative expression of collagen III and peri-
ostin, both markers of ligamentous tissue, throughout the 
soft tissue region (Figure 4A). However, those groups that 
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Figure 4. PDL-like tissue formation using micropatterned scaffolds with gene delivery. A) Immunofluorescence analysis of ligamentous tissue forma-
tion at defect site. The expression of collagen III and periostin is more homogenous in groups with micropatterning and gene delivery, indicating greater 
maturity. DAPI is a nuclear stain, and collagen III and periostin are markers of ligamentous tissue. Scale bar is 100 µm for all images. Dashed white lines 
represent regions of PDL-like tissue formation along the tooth root where PDL and cementum were removed during defect creation. TR = tooth root, 
B = bone. B) Periostin expression ratio for regenerated soft tissue to native PDL (n = 6 per group). Data shown as mean ± SD. Statistics performed as 
one-way ANOVA with Tukey’s post hoc comparisons within each time point and two-sided p-values of *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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also had patterning (i.e., Pattern+Single 
and Pattern+Dual) showed more consistent, 
homogeneous expression, as would be antici-
pated of mature PDL. Similar, although 
more modest, results are evident at three 
weeks (Supporting Information, Figure 2). 
An analysis of the ratio of mean periostin 
intensity in the regenerated versus native tis-
sues (or injured (lingual side) versus injured/
regenerated side (buccal side) (Figure 4B) 
shows significantly higher (albeit modestly 
increased) expression at three weeks for 
the Pattern+Single group compared to the 
Amor+Empty group. Overall, at three weeks 
the ratios are nonsignificant and lower for 
the Amor+Empty and Pattern+Empty groups 
compared to all groups with growth factor 
delivery. This indicates that the patterning 
may have a very modest reinforcing effect on 
PDL-like tissue formation over time, in com-
bination with growth factor expression.
Taken together, these results suggest that, 
although the combined treatment may not 
have produced more ligamentous tissue than 
the other groups, its tissue was more mature 
and PDL-like. The results of the present study 
showed that the ratio of periostin expression 
in regenerated versus native tissues varied 
little between groups. Surface topography 
appears to modestly enhance PDL regenera-
tion. In a previous study, combined delivery 
of AdBMP-7 and AdPDGF via scaffolds con-
tributed to a more robust regeneration of 
the periodontium than separate delivery of 
either.[11] Here, however, comparable bone 
regeneration was observed in groups with 
single and dual gene delivery, and PDL-like 
tissue was evident in patterned groups with 
single and dual delivery.
In human nuclear staining for Amor+Dual 
and negative control, human-derived cells 
remained at the defect site even nine weeks 
postimplantation, more characteristic of an 
immunodeficient animal model allowing 
for the longer residence of implanted cells 
(Figure 5).
2.4. Mechanical Properties of Tissues, Assessed 
by Nanoindentation
Alveolar bone and PDL are load-bearing tissues that integrate 
over time, making the parameters of stiffness and hardness 
important for determining whether the regenerated tissue is 
mechanically similar to its native counterpart. Nanoindenta-
tion was done on the experimental group (Pattern+Dual) and 
negative control (Amor+Empty) after three and nine weeks to 
evaluate the mechanical properties of the regenerated tissues 
(Figure 6). These groups were specifically selected in order to 
compare and contrast the mechanical properties of the negative 
and positive controls so as to extract the most relevant findings 
rather than comparing all groups at once. At the same time, 
other groups were not taken out to nine weeks to assess tissue 
regeneration via immunofluorescence, histology, and micro-CT 
given that the rat fenestration defect model used in this study 
is known to have a rapid healing rate, giving the expectation 
that assessments at three and six weeks would suffice to deter-
mine the extent of PDL and osseous tissue regeneration, as was 
found to be true.
The elastic modulus (or stiffness) and hardness were meas-
ured for both regenerated and native tissues. Values are reported 
as ranges due to the heterogeneity of the tissue architecture, as 
Adv. Healthcare Mater. 2018, 7, 1800750
Figure 5. Immunohistochemistry for human cells. Human cells remaining in the defect after 3, 
6, and 9 weeks of healing were stained with antihuman nuclear stain, MACH4, to illustrate the 
degree to which they contributed to regeneration relative to native rat cells. The remnants of 
amorphous scaffold take on a nonspecific brown stain; therefore, the human nucleus-positive 
cells were identified using both the brown stain of MACH4 and blue stain of hematoxylin. Yellow 
arrows indicate regions with many human cells. Scale bar is 100 µm for all images. Boxes 
indicate the magnified regions of the images to the right. TR = tooth root, AS = amorphous 
scaffold, B = bone.
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has been done previously.[24] At three weeks, the regenerated 
bone of the negative control was significantly less stiff than 
native bone (Figure 6C), and at nine weeks, the new bone and 
PDL-like tissue were less stiff than native (Figure 6A,C,D). By 
contrast, the stiffness of the experimental group’s regenerated 
tissues was statistically indistinguishable from that of native 
at three and nine weeks. This suggests greater maturity of 
the regenerated tissues of the experimental group relative to 
the control. However, for hardness, both groups’ tissues were 
generally less hard than native, and at nine weeks, the regener-
ated bone of the experimental group was less hard than that 
of the negative control (Figure 6B). While elastic modulus 
property (resistance to elastic deformation in the presence of 
an applied load) represents the tissue’s intrinsic material, hard-
ness (resistance to localized surface deformation) indicates an 
extrinsic or structurally based response. In general, an increase 
in both bone tissue stiffness and hardness is expected with 
increasing time points, with higher ranges for PDL and bone 
tissues in the experimental group relative to the negative con-
trol. The increase in stiffness of bone and PDL tissues in the 
experimental group relative to the negative control group is 
observed, while the hardness range is shown to be on the lower 
end for the experimental group relative to the negative control 
group. Presence of increased tissue mineralization in negative 
control samples can increase tissue hardness, which is a pos-
sibility given that the negative control samples may be at risk of 
ankylosis-like formations as a result of regenerative responses 
(without intervening PDL soft vs osseous tissue formation) that 
could be verified histologically over longer periods of time than 
what was observed in this study at weeks 3 and 6. Addition-
ally, it is worthwhile to note that the resulting PDL-like tissue 
mechanical properties are also affected by the lack of integra-
tion between PDL tissue and regenerated bone, as is the case in 
native periodontium, thereby changing the stiffness and hard-
ness of these tested regenerated PDL samples when compared 
to native PDL tissues. The histological samples reveal that the 
soft PDL-like tissues do not have any defined points of integra-
tion, instead showing distinct areas of either soft or osseous 
tissue formation. Potential changes to the scaffold design that 
results in a more integrated scaffold to begin with instead of 
two separate regions, may contribute to a more natural inte-
gration between these two tissue types over the course of the 
regenerative process.
Overall, the values observed for the native bone and PDL 
here correspond to those of other studies.[24,25] That said, it is 
important to note that a variety of technical factors may affect 
the stiffness and hardness ranges, including the hydration state 
(i.e., testing under wet vs dry conditions), probe geometry, and 
loading conditions. Moreover, the heterogeneity of values in the 
bone tissue is specifically identifiable using nanoindentation, 
as compared with microindentation, given that there are het-
erogeneous regions of lamellar bone integrating with bundle 
bone, thereby resulting in a range of values. On the whole, 
the nanoindentation data indicate that, with respect to stiff-
ness, the experimental group more closely approximated the 
mechanical properties of native tissue than the negative con-
trol, but that both tissues had not yet reached full maturity, as 
shown by hardness.
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Figure 6. Nanoindentation to assess tissue mechanical properties. A,B) Measurements of the reduced elastic modulus (or stiffness) and hardness of 
regenerated and native tissues for the experimental group and negative control. Native measurements were taken from uninjured tissue adjacent to the 
defects and pooled between the two groups. Tukey’s box plots compare the stiffness of tissues at C) three weeks and D) nine weeks postimplantation, 
using data from (A). The regenerated tissues of the negative control are, in 3 of 4 tissues and time points, less stiff than native tissues, while those of 
the experimental group are statistically indistinguishable from the native tissue. Data shown as ranges for (A) and (B) and as mean ± SD for (C) and 
(D). Statistical comparisons were made between the experimental group, negative control, and native tissue for each tissue type at each time point 
(n = 15 per tissue region), using one-way ANOVA with Tukey’s post hoc comparisons and two-sided p-values of */#/^p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001.
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3. Conclusions
This study aimed to evaluate the effects of combining surface 
topography with growth factor gene delivery on periodontal 
tissue regeneration. The results indicate that the combination 
better regenerates the bone–PDL interface than either treat-
ment alone. Delivery of growth factor genes, principally 
AdPDGF-BB and AdBMP-7, improves bone formation, and 
surface topography incorporated into the scaffold as micropat-
terning was important for the formation of PDL-like tissue 
and the overall integrity of the bone–PDL interface. This study 
adds nuance to strategies that use biomaterials for regenerative 
treatments for periodontal and other diseases. It also adds to 
previous knowledge that micropatterning can enhance tissue 
responses, and that gene therapy vectors can be immobilized 
onto a scaffold surface to localize the transduction of cells in 
vivo. Future work is needed to calibrate the effects of scaffold 
topography to activate the appropriate cellular responses for 
regenerating specific tissue types, as well as develop a process 
for scaffold fabrication that permits transduction to occur in 
vivo instead of in vitro prior to implantation.
4. Experimental Section
Preparation of Biphasic Scaffolds with Micropatterned and Amorphous 
Regions: A CAD-based program (Tanner L-Edit IC, Mentor, Siemens, 
Munich, Germany) was used to design the micropatterns of the scaffolds 
and master molds with the parameters necessary for an alveolar bone 
defect. Design specifications for the micropatterns consisted of the 
following: pillar height of 100 µm, interpillar distance of 150 µm, pillar 
length × width of 150 µm × 150 µm, and grooves of 15 µm width × 30 µm 
depth (Figure 1B). The pillar height approximated the thickness of native 
rat PDL as identified in pilot studies (data not shown). SU-8 master 
molds were fabricated at Lurie Nanofabrication Facility (University of 
Michigan, Ann Arbor, MI) using standard photolithography as previously 
described.[7] Briefly, polydimethylsiloxane (PDMS, Sylgard 184, Dow 
Corning, Midland, MI) was mixed in a ratio of 10:1 v/v of base to curing 
agent, degassed under vacuum, poured onto SU-8 master molds, cured 
at 65 °C, and peeled to reveal the pattern.
Fabrication of the PDL Region: A solution of 5% poly(d,l-lactic-co-
glycolic acid) (75:25 lactic:glycolic, 137 kDa, Evonik Industries, Essen, 
Germany) and polycaprolactone (45 kDa, Sigma-Aldrich, St. Louis, MO) 
in a 1:1 ratio by weight was used to cast the pillars within a PDMS mold. 
To complete the PDL region, a solution of 10% PCL was layered onto 
the precast pillars while adding sugar particles (≤75 µm), in order to 
create a base of 150 µm thickness. After drying under vacuum overnight, 
the sugar was leached out in deionized water, leaving porosity for cell 
growth.
Fabrication of the Bone Region: A porous, amorphous PCL scaffold 
was formed in a similar manner as for the PDL region’s base, with a final 
thickness of 250 µm, such that the combined biphasic scaffold construct 
could fit within a 0.5 mm deep fenestration defect.
In order to test the effect of topography on PDL regeneration, an 
amorphous, porous PCL/PLGA (1:1 by weight) PDL region with a total 
thickness of 250 µm was formed using the same technique as the bone 
region. This monophasic scaffold represented the unpatterned control.
CVD and Gene Therapy Vector Immobilization: Following scaffold 
fabrication, each region of the scaffold was separately coated with a 
layer of amine-reactive polymer using a custom-built CVD system, 
as previously reported..[14,17] Briefly, the scaffolds were fixed inside 
the deposition chamber at 15 °C, and the pentafluorophenyl ester-
substituted paracyclophane dimer was sublimated at 120 °C, pyrolyzed 
at 540 °C to form a stream of reactive diradical vapor, and deposited and 
polymerized on the scaffold surface (pressure of 0.1 mbar, with argon as 
the carrier gas). The scaffolds were then turned over and coated again to 
ensure that the coating deposited on all sides. The scaffolds were stored 
under vacuum until further use or sterilized in 70% ethanol to prepare 
for adenoviral immobilization onto their surfaces, as needed.
For gene immobilization, scaffolds were treated with anti-adenovirus 
antibodies and adenoviruses, as previously reported.[14] Briefly, after 
sterilization, scaffolds were incubated with 10 µg mL−1 goat anti-
adenovirus polyclonal antibody (0151-9004, AbD Serotec, Bio-Rad 
Laboratories, Hercules, CA) in phosphate-buffered saline (PBS) at 4 °C 
overnight, based on a previously established saturation point. They were 
then rinsed 5 × 5 min with PBS, incubated in 12 mL of 1012 particles 
(PN) mL−1 cold adenovirus solution at 4 °C for 4 h and rinsed 5 × 5 min 
with PBS. After the final PBS wash, the scaffolds were ready for cell 
seeding.
Replication-deficient adenoviruses containing the genes of interest 
were prepared by the University of Michigan Vector Core. During the 
adenoviral incubation, experimental scaffolds received AdBMP-7 for 
their bone regions (i.e., amorphous PCL scaffold) and AdPDGF-BB or 
BMP-7 for their PDL regions (i.e., porous micropatterned PLGA film) 
(Figure 1A). Control groups received adenoviruses encoding nonsense 
vectors (Ad-empty) for their bone and PDL regions.
Cell Seeding: hPDLs (primary cells from PDL, No. 2630, ScienCell, 
Carlsbad, CA) were grown in Dulbecco’s Modified Eagle Media (DMEM, 
Thermo Fisher, Ann Arbor, MI) with 5% fetal bovine serum (FBS) at 
37 °C. hGFs (primary cells from gingiva, No. 2620, ScienCell) were grown 
in DMEM with 10% FBS at 37 °C. The day prior to surgical implantation, 
5 × 105 hPDLs were seeded onto the PDL regions of the scaffolds 
(except the single-gene delivery group, for which hGFs were seeded 
onto the patterned, AdBMP-7-coated PDL region), and 5 × 105 hGFs 
were seeded onto the bone regions. The cells were allowed to attach 
before transferring the scaffolds into fresh medium and incubating at 
37 °C until surgery. The selection of hGFs for seeding of the bone region, 
instead of human osteoblasts, was based on the fact that these cells are 
more easily accessible clinically and that the transduction of these cells 
with Ad-BMP7 results in formation of bone that occurs more rapidly 
and in similar bone formation as would be expected with the use of 
human osteoblasts alone. At the same time, this approach is intended 
to provide greater control over the location of bone formation within the 
scaffold region by immobilizing the vector through CVD-based coating 
onto polymer surface in regions of interest, instead of randomly seeding 
osteoblasts without more spatiotemporal control over at least the initial 
expression of BMP7 in the scaffold.
Scanning Electron Microscopy: CVD-coated scaffolds with and without 
hPDL seeding were imaged by SEM. Those with cells were prepared for 
imaging 3 d after seeding by fixing with 2.5% glutaraldehyde at 4 °C 
overnight, dehydrating with ethanol, and washing three times with 
hexamethyldisilazane (HMDS). Scaffolds were mounted using graphite 
conductive adhesive (No. 12691-30, Electron Microscopy Sciences, 
Hatfield, PA), gold-sputter coated, and observed at an acceleration 
voltage of 5 kV using an AMRAY FE 1900 SEM (SEMTech Solutions, 
Billerica, MA) at the Microscopy and Image Analysis Laboratory 
(University of Michigan).
Barium Sulfate Treatment: To visualize a scaffold’s adaptation to the 
fenestration defect, a full scaffold (i.e., both the micropatterned PDL 
and bone regions) was immersed in 20% barium sulfate in water for 
30 min, prior to being placed into a rat fenestration defect (3 × 2 mm) 
on a defleshed, cadaver mandible and scanned using micro-CT, as 
detailed below.
In Vivo Implantation: Rat Fenestration Defect: The in vivo study 
design consisted of the following five groups, all CVD-coated and cell-
seeded: (1) a negative control with Ad-empty, amorphous PDL region 
and Ad-empty bone region (Amor+Empty); (2) Ad-empty, patterned 
PDL and Ad-empty bone (Pattern+Empty); (3) AdBMP-7, patterned 
PDL and AdBMP-7 bone (with hGF cells in both, Pattern+Single); 
(4) AdPDGF-BB, amorphous PDL and AdBMP-7 bone (Amor+Dual); 
and (5) the experimental treatment with AdPDGF-BB, patterned PDL and 
AdBMP-7 bone (Pattern+Dual) (Figure 1A). The time points that tested 
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tissue regeneration were at three and six weeks. For the three-week 
time point, Amor+Empty and Pattern+Dual had a total n = 10, and the 
remaining groups (Pattern+Empty, Pattern+Single, Amor+Dual) had n = 
6 because these groups were not used for additional nanoindentation 
assessments. For the six-week time point, all groups had n = 6 to allow 
for micro-CT, immunofluorescence, and histological assessments. 
Amor+Empty, Amor+Dual, and Pattern+Dual were also extended to 
nine weeks (n = 5) to evaluate the retention of human-based cells and 
the mechanical properties of regenerated bone and PDL-like tissue 
compared to native tissues.
All animal procedures were performed with approval of the University 
of Michigan-University Committee on Use and Care of Animals 
(UM-UCUCA) according to ARRIVE guidelines for preclinical studies. 
Athymic male rats (250 g, Charles River Laboratories, Wilmington, 
MA) were ordered, administered preemptive subcutaneous analgesic 
(5 mg kg−1 carprofen), and put under general anesthesia with isofluorane 
during periodontal defect creation. A single fenestration defect (3 mm 
width × 2 mm height) was created for each animal on the buccal side 
of the right mandible, such that the distal root of the first molar tooth 
was exposed (Supporting Information, Figure 1). The cementum layer 
was carefully removed to expose the dentin surface, after which the PDL 
region of the scaffolds was positioned with the pillars facing the dentin, 
followed by the bone region directly adjacent. The site was closed with 
sutures and surgical staples, with subcutaneous administration of 
analgesic 24 h postsurgery. After 3, 6, and 9 weeks, specimens were 
harvested and fixed in 10% buffered formalin phosphate solution for 2 d 
before being transferred into 70% ethanol for micro-CT scanning.
Micro-CT and Histomorphometry: Micro-CT was used to evaluate 
bone regeneration postimplantation and scaffold adaptation. Tissue-
fixed specimens were embedded in alginate, scanned using a µCT 
100 cabinet micro-CT scanner (Scanco Medical, Brüttisellen, Switzerland) 
at a resolution of 12 µm, 70 kV energy, and 114 µA intensity, and 
calibrated to Hounsfield units (HU). Total bone volume, bone fill percent, 
and TMD were determined for regenerated bone in the healed defects 
using Microview (Parallax Innovations, Ilderton, Ontario, Canada) at a 
threshold of HU = 1050 for bone (n = 6–10 per group). After scanning, 
samples were decalcified in 10% EDTA, embedded in paraffin, and cut 
into 5 µm sections for histological analysis.
Some sections were stained with toluidine blue for histomorphometric 
analysis. Soft tissue width was determined by measuring from the 
scaffold or newly formed bone to the tooth root at three points on 
each sample: near the two edges of the scaffold (at the farthest pillar, 
if applicable) and at its center; these three measurements were then 
averaged for the sample (Figure 3B) (n = 3–6 samples, depending on the 
group and time point).
Other sections were stained with H&E to evaluate soft tissue 
formation. Some of those also underwent human nuclear staining 
performed using immunohistochemistry. The 5 µm sections were 
dewaxed and incubated in DIVA antigen retrieval solution (Biocare 
Medical, Concord, CA) at 60 °C overnight. Next, they were incubated 
with 3% bovine serum albumin (BSA) for blocking of unspecific binding 
followed by incubation overnight at 4 °C with primary antibody (mouse 
antihuman nuclei monoclonal antibody, diluted 1:100, MAB1281, EMD 
Millipore Corp, Temecula, CA), overnight at 4 °C. The sections were then 
incubated with MACH4 polymer (Biocare Medical) for 30 min. Positive 
cells were detected using DAB substrate (Biocare Medical) plus the H&E 
counterstain.
Immunofluorescence: Sections of 5 µm thickness were dewaxed, 
rehydrated, and incubated in DIVA antigen retrieval solution (Biocare 
Medical) at 60 °C overnight (n = 6 for all groups). Following blocking 
of unspecific binding using 3% BSA, the sections were incubated at 4 °C 
overnight with primary antibodies for anti-periostin (rabbit polyclonal, 
ab14041, Abcam, Cambridge, MA) and anti-collagen III (mouse 
monoclonal, ab6310, Abcam) at 1:500 dilutions. The sections were 
then incubated with Alexa-conjugated secondary antibodies at a 1:200 
dilution for 2 h at room temperature (Alexa-488 anti-mouse, ab150113, 
and Alexa-555 anti-rabbit, ab150074, Abcam). Controls did not use the 
primary antibody in the protocol. The comparison of antibody staining 
for periostin contrasted the buccal (injured and/or regenerated bone 
defect area) versus the lingual (uninjured, nonsurgically treated bone). 
4′,6-Diamidino-2-phenylindole (DAPI) was additionally used to visualize 
cell nuclei (Prolong Gold Antifade Reagent with DAPI, Life Technologies, 
Carlsbad, CA).
Nanoindentation: Mandibulae reserved for nanoindentation were 
frozen after harvesting at three and nine weeks postimplantation. 
Samples were prepared for mechanical testing as follows: thawing 
the frozen sample, trimming the mandible to retain only the molars 
by cutting off the incisors and ramus using a low-speed diamond 
wheel saw (South Bay Technology, San Clemente, CA), embedding the 
trimmed sample in epoxy resin (EMBED 812 Embedding Kit, Electron 
Microscopy Sciences, Hatfield, PA), sectioning using a microtome (Leica 
Biosystems, Wetzlar, Germany), polishing using silicon carbide abrasive 
paper (2400 grit) under water irrigation for 2 min, and cleansing to 
remove particles using ultrasonication in water for 15 min.
Nanoindentation was performed using the 950 TI TriboIndenter 
(Hysitron Incorporated, Minneapolis, MN) at the Michigan Center for 
Materials Characterization (MC2, University of Michigan). The sample 
was glued to a steel stub (Ted Pella, Altadena, CA) and indented using a 
standard Berkovich diamond probe with a penetration depth of 500 nm 
and 3 s for each load, hold, and unload.[24,25] Fused silica was used as 
the calibration standard. The reduced modulus (Er) and hardness (H) 
were calculated using the load–displacement curve based on five indents 
(each 10 µm apart, in accordance with ASTM standards) at the following 
four regions for each sample: (1) regenerated PDL-like tissue at the 
original defect site, (2) regenerated alveolar bone, (3) native alveolar 
bone at the region directly opposite the defect site, and (4) native PDL 
(n = 3 samples × 5 indentations for each tissue region).
Specifically, the Er (GPa) is calculated based on Oliver–Pharr analysis 
using Equation (1), where S (µN nm−1) is the contact stiffness (obtained 
from the unload curve slope, where P is the indentation force and h is 












The hardness, H (MPa), is calculated using Equation (2), where Pmax 









Statistical Analysis: Data were expressed as mean ± standard deviation 
for all graphs, save for the tables in Figure 6 where ranges are shown. 
Using GraphPad Prism, one-way analysis of variance (ANOVA) with 
post hoc Tukey’s multiple comparison method was used to perform 
comparative analysis within each time point and a two-sided p-value of 
less than 0.05 (α < 0.05) considered significant. Levels of significance 
are indicated in the figure legends. Sample sizes for the analyses are as 
follows: n = 6–10 depending on the group and time point for bone 
volume, bone fill percent, and tissue mineral density; n = 6 for periostin 
expression ratio; n = 3–6 for soft tissue width; n = 15 for nanoindentation 
(3 samples × 5 indentations per tissue type).
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